CMTX Biotech, Inc

CMTx Biotech, Inc., based in Kings Park, NY, specializes in the commercialization of proprietary small molecules aimed at treating rare and pandemic diseases to enhance critical patient outcomes. The company has successfully completed IND-enabling studies and has advanced its lead drug candidate into human clinical trials, demonstrating proven safety across various indications.

The management team at CMTx Biotech comprises experienced professionals in drug development, technology commercialization, and licensing, with a track record of multiple successes. Their advisory board includes notable scientists and industry experts who contribute to the strategic direction and scientific integrity of the company's initiatives.

Generated from the website